drug-refractory epilepsy
Conditions
Interventions
Treatment group:Implantable neurostimulation needle electrodes are used to monitor intracranial EEG in patients with drug-refractory epilepsy
Sponsors
The First Affiliated Hospital of Xi'an Jiaotong University
Eligibility
Sex/Gender
All
Age
6 Years to 60 Years
Inclusion criteria
Inclusion criteria: (1) Male or female = age 6 years old and = 60 years old; (2) Previous diagnosis of drug-refractory epilepsy; (3) Those who have seizures at least once a month; (4) Those who intend to undergo stereotactic EEG monitoring; (5) Those who have not participated in other clinical trials within three months; (6) The subjects or their guardians can understand the purpose of the trial, comply well with the trial protocol, voluntarily participate and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients with severe coagulation disorders; (2) Those who are allergic to electrode materials; (3) Those who have a pacemaker or other active implant in the body; (4) Patients with contraindications to neurosurgery and severe cardiovascular and cerebrovascular diseases; (5) Systemic diseases that seriously affect health, such as severe abnormalities in liver and kidney function; (6) Pregnant women or women who intend to become pregnant in the past six months, or lactating women; (7) Those who are considered unsuitable by the investigator to participate in clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| success rate of intracranial EEG signal recording; | — |
Secondary
| Measure | Time frame |
|---|---|
| The investigator's evaluation of the performance of the device; | — |
Countries
China
Contacts
Public ContactZhang Hua
The First Affiliated Hospital of Xi'an Jiaotong University
Outcome results
None listed